Literature DB >> 2296564

Nutritional deficiencies in patients receiving cancer chemotherapy.

S Dreizen1, K B McCredie, M J Keating, B S Andersson.   

Abstract

Cancer often causes malnutrition and specific vitamin and protein deficiencies. Chemotherapy also causes deficiencies by promoting anorexia, stomatitis, and alimentary tract disturbances. Antimetabolite drugs in particular inhibit synthesis of essential vitamins, purines, and pyrimidines. Because vitamin levels in the blood are often nondiagnostic, nutritional deficiency is identified almost exclusively on the basis of clinical signs and symptoms and the patient's response to therapy. Signs and symptoms of cachexia and hypoalbuminemia are common in patients with advanced cancer. Deficiencies of vitamins B1, B2, and K and of niacin, folic acid, and thymine also may result from chemotherapy. Nutritional deficiencies are chemically correctable; however, the tumor must be eradicated to relieve cachexia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296564     DOI: 10.1080/00325481.1990.11704531

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  9 in total

1.  Role of cysteine residues in cell surface expression of the human riboflavin transporter-2 (hRFT2) in intestinal epithelial cells.

Authors:  Veedamali S Subramanian; Laramie Rapp; Jonathan S Marchant; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

2.  Differential expression of human riboflavin transporters -1, -2, and -3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake.

Authors:  Veedamali S Subramanian; Sandeep B Subramanya; Laramie Rapp; Jonathan S Marchant; Thomas Y Ma; Hamid M Said
Journal:  Biochim Biophys Acta       Date:  2011-08-11

Review 3.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

4.  Role of nicotinamide in DNA damage, mutagenesis, and DNA repair.

Authors:  Devita Surjana; Gary M Halliday; Diona L Damian
Journal:  J Nucleic Acids       Date:  2010-07-25

Review 5.  Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review.

Authors:  Julia E Inglis; Po-Ju Lin; Sarah L Kerns; Ian R Kleckner; Amber S Kleckner; Daniel A Castillo; Karen M Mustian; Luke J Peppone
Journal:  Nutr Cancer       Date:  2019-01-26       Impact factor: 2.900

Review 6.  Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.

Authors:  Tamhida Masi; Bhoomika M Patel
Journal:  Pharmacol Rep       Date:  2020-11-03       Impact factor: 3.024

7.  Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC).

Authors:  Inja Ilic; Anna-Laura Potthoff; Valeri Borger; Muriel Heimann; Daniel Paech; Frank Anton Giordano; Leonard Christopher Schmeel; Alexander Radbruch; Patrick Schuss; Niklas Schäfer; Ulrich Herrlinger; Hartmut Vatter; Asadeh Lakghomi; Matthias Schneider
Journal:  Cancers (Basel)       Date:  2022-09-24       Impact factor: 6.575

8.  Kynurenine Pathway Pathologies: do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2013-07-21

9.  Cost-Effectiveness of Nutrient Supplementation in Cancer Survivors.

Authors:  Amy L Shaver; Theresa A Tufuor; Jing Nie; Shauna Ekimura; Keri Marshall; Susan Hazels Mitmesser; Katia Noyes
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.